Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KriSan Biotech
Xinshi, Tainan, Taiwankrisanbiotech.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
KriSan Biotech is an international CDMO specializing in complex small molecules, peptides, oligonucleotides (including LNP formulations), antibody-drug conjugates (ADC), and peptide-drug conjugates. The company has completed over 90 projects for more than 45 global clients across the US, Europe, Japan, Middle East, Singapore, and Taiwan. It holds PIC/S GMP certification and supports customers from preclinical through commercial production.
- Modalities
- Small moleculePeptidesOligonucleotideAntibody-drug conjugate (ADC)Peptide-drug conjugate (PDC)Lipid nanoparticle delivery therapy (for oligonucleotides)
- Industry
- Contract Manufacturing Organization
02
Partnerships
Sartorius – technical partnership for ADC drug substance production line buildout.Mycenax Biotech – collaboration on ADC design/development/manufacturing value chain.OncoArendi Therapeutics – supply agreement for active pharmaceutical ingredients from Pre‑IND to Phase II clinical trials.晟德集團（Synmosa Group）– strategic investor/partner since late 2023永昕生醫（Mycenax Biotech）– strategic investor/partner since late 2023
Beyond the preview
Go deeper on KriSan Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KriSan Biotech.